Raise closed, search for fresh raises on Seedstage

Mesa, AZ

Transforming regenerative medicine through real-world evidence collection and analysis to empower healthcare providers and patients.

• Mission: Transforming regenerative medicine by providing healthcare providers with a standardized platform to collect, analyze, and share real-world evidence to enhance patient care and outcomes.  
• Innovation: A data-driven software platform that empowers healthcare providers to make informed, evidence-based decisions while promoting transparency and co-ownership of patient data.  
• Market Opportunity: Positioned to meet the growing demand for personalized, less invasive healthcare solutions, particularly in regenerative medicine, amidst an aging population and evolving regulatory landscapes.  
• Funding Uses: Enhancing platform capabilities, expanding market reach, and continuing to lead in evidence-based regenerative medicine.  
• Impact on Healthcare: Improving trust in cash-pay medical options like PRP and stem cell therapies by bridging the gap in credible data and fostering collaboration among healthcare providers.  
• Strategic Positioning: Serving over 200 providers across North America, DataBiologics is gaining momentum through organic referrals from early adopters who recognize its value in advancing patient care.

DataBiologics is dedicated to transforming the field of regenerative medicine by providing a standardized software platform that enables healthcare providers to collect, analyze, and share real-world evidence regarding treatments like platelet-rich plasma (PRP) and stem cell therapies.

This initiative addresses the critical gap in credible data that has historically hindered the adoption of such therapies, which are often viewed as unregulated and lacking predictable outcomes. By harnessing real patient feedback, DataBiologics aims to empower both physicians and patients to make informed treatment choices, ultimately improving patient care and fostering trust in cash-pay medical options.

The company has seen significant growth, serving over 200 providers across the U.S. and Canada, driven largely by organic referrals from early adopters who recognize the platform’s value. With an aging population increasingly seeking personalized and less invasive healthcare solutions, DataBiologics is well-positioned to meet this demand while also aligning with evolving regulatory requirements that emphasize the importance of patient-reported outcomes.

Through this fundraising effort, DataBiologics seeks to enhance its platform, expand its market reach, and continue leading the way in evidence-based regenerative medicine.

Company Info

DataBiologics provides data-driven solutions to enhance patient care and optimize clinical practices.

DataBiologics is a company focused on transforming real-world data into actionable insights to enhance patient care and practice growth. It aims to provide healthcare providers with accessible and affordable data solutions, which are crucial for building trust and marketing their successes, particularly in cash-pay areas such as regenerative medicine. The platform enables the collection and analysis of patient-reported outcomes across various touchpoints, thereby offering objective clinical data that can elevate clinical practices and optimize patient outcomes. DataBiologics promotes collaboration among healthcare providers and industry allies to advance medical frontiers. Their software supports personalized care by allowing physicians to make data-driven decisions and encourages patient engagement. The company also emphasizes data transparency and co-ownership, ensuring that clinics retain ownership of their collected data while allowing DataBiologics to license it for research or commercial purposes.